Inventor · disambiguated record
Krzysztof Masternak
Also filed as: MASTERNAK KRZYSZTOF · MASTERNAK KRZYSZTOF M
14 granted patents·8 pending applications·62 citations·filing 2001–2024
90Inventor score
Top patents by PatentIndex Score
22 records- 0194US8715669B2Anti-IL-17A/IL-17F cross-reactive antibodiesMASTERNAK KRZYSZTOF·Filed 2011·Granted May 6, 2014·32 cites·19 claims
- 0289US12448444B2Bispecific antibodies targeting CD47 and PD-L1 and methods of use thereofNOVIMMUNE SA·Filed 2022·Granted Oct 21, 2025·2 cites·35 claims
- 0389US11260117B2Anti-CD47 x anti-mesothelin antibodies and methods of use thereofNOVIMMUNE SA·Filed 2018·Granted Mar 1, 2022·4 cites·18 claims
- 0488US8771697B2Methods of treatment using anti-IL-17A/IL-17F cross-reactive antibodiesMASTERNAK KRZYSZTOF·Filed 2012·Granted Jul 8, 2014·10 cites·17 claims
- 0583US8609093B2Methods of treatment using anti-IL-17F antibodiesMASTERNAK KRZYSZTOF·Filed 2012·Granted Dec 17, 2013·6 cites·12 claims
- 0679US8137671B2Anti-IL-17F antibodiesMASTERNAK KRZYSZTOF·Filed 2010·Granted Mar 20, 2012·4 cites·6 claims
- 0778US2024400720A1Anti-cd47 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2024·Application pending·0 cites
- 0873US11059910B2Anti-CD47 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2013·Granted Jul 13, 2021·1 cites·7 claims
- 0972US9815909B2Readily isolated bispecific antibodies with native immunoglobulin formatNOVIMMUNE SA·Filed 2013·Granted Nov 14, 2017·1 cites·10 claims
- 1072US9650437B2Nucleic acid encoding and method of producing anti-IL-17A/IL-17F cross-reactive antibodiesNOVIMMUNE SA·Filed 2013·Granted May 16, 2017·1 cites·20 claims
- 1172US9475873B2Nucleic acids encoding anti-IL-17F antibodies and methods of use thereofNOVIMMUNE SA·Filed 2014·Granted Oct 25, 2016·1 cites·13 claims
- 1265US2009317400A1Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use ThereofMASTERNAK KRZYSZTOF·Filed 2009·Application pending·0 cites
- 1364US2020231707A1Readily isolated bispecific antibodies with native immunoglobulin formatNOVIMMUNE SA·Filed 2019·Application pending·0 cites
- 1463US11840553B2Anti-CD47 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2018·Granted Dec 12, 2023·0 cites·2 claims
- 1561US10494446B2Readily isolated bispecific antibodies with native immunoglobulin formatNOVIMMUNE SA·Filed 2017·Granted Dec 3, 2019·0 cites·7 claims
- 1660US2024254234A1PD-L1xCD28 BISPECIFIC ANTIBODIES FOR IMMUNE CHECKPOINT-DEPENDENT T CELL ACTIVATIONNOVIMMUNE SA·Filed 2023·Application pending·0 cites
- 1758US2014099322A1Anti-il-17f antibodies and methods of use thereofNOVIMMUNE SA·Filed 2013·Application pending·0 cites
- 1856US2024002544A1Cd28 bispecific antibodies for targeted t cell activationNOVIMMUNE SA·Filed 2023·Application pending·0 cites
- 1954US2002156258A1Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substancesFiled 2001·Application pending·0 cites
- 2047US11261262B2Readily isolated bispecific binding molecules with native format having mutated constant regionsNOVIMMUNE SA·Filed 2014·Granted Mar 1, 2022·0 cites·23 claims
- 2144US11401299B2Generating multispecific antibody mixtures and methods of uses thereofNOVIMMUNE SA·Filed 2018·Granted Aug 2, 2022·0 cites·3 claims
- 2244US2005260661A1Assays for the identification of modulators of MHC class II expressionMACH BERNARD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Krzysztof Masternak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →